Dihydromyricetin - PMC

Result Filters

You searched 8+ million full text articles

Try this search in 34+ million citations and abstracts

PMC Full-Text Search Results

Items: 1 to 20 of 3066

<< First< Prev

Page of 154

Next >Last >>

Select item 83495621.

Effect of dihydromyricetin on SARS-CoV-2 viral replication and pulmonary inflammation and fibrosis

Ting Xiao, Yuli Wei, Mengqi Cui, Xiaohe Li, Hao Ruan, Liang Zhang, Jiali Bao, Shanfa Ren, Dandi Gao, Ming Wang, Ronghao Sun, Mingjiang Li, Jianping Lin, Dongmei Li, Cheng Yang, Honggang Zhou

Phytomedicine. 2021 Oct; 91: 153704. Published online 2021 Aug 8. doi: 10.1016/j.phymed.2021.153704

PMCID:: PMC8349562

Abstract Article PDF–8.2M

Select item 112997852.

Dihydromyricetin Inhibits Ferroptosis to Attenuate Cisplatin-Induced Muscle Atrophy

Lijiang YOU

Physiol Res. 2024 Jun; 73(3): 405–413. Published online 2024 Jun 30. doi: 10.33549/physiolres.935317

PMCID:: PMC11299785

Abstract Article PDF–1.5M

Select item 98769413.

Extracting myricetin and dihydromyricetin simultaneously from Hovenia acerba seed by Ultrasound-Assisted extraction on a lab and small Pilot-Scale

Xiaonan Zhang, Lubin Zhang, Yingdi Zhang, Tingting Xiong, Yaqian Niu, Yan Huang

Ultrason Sonochem. 2023 Feb; 93: 106304. Published online 2023 Jan 18. doi: 10.1016/j.ultsonch.2023.106304

PMCID:: PMC9876941

Abstract Article PDF–1.9M

Select item 79792834.

Dihydromyricetin Acts as a Potential Redox Balance Mediator in Cancer Chemoprevention

Liang Chen, Meng Shi, Chenghao Lv, Ying Song, Yuanjie Wu, Suifei Liu, Zhibing Zheng, Xiangyang Lu, Si Qin

Mediators Inflamm. 2021; 2021: 6692579. Published online 2021 Mar 11. doi: 10.1155/2021/6692579

PMCID:: PMC7979283

Abstract Article PDF–609K

Select item 95182665.

Strategic developments in the drug delivery of natural product dihydromyricetin: applications, prospects, and challenges

Ruirui Zhang, Hao Zhang, Houyin Shi, Dan Zhang, Zhuo Zhang, Hao Liu

Drug Deliv. 2022; 29(1): 3052–3070. Published online 2022 Sep 22. doi: 10.1080/10717544.2022.2125601

PMCID:: PMC9518266

Abstract Article PDF–2.5M

Select item 63900356.

Protective effect of dihydromyricetin revents fatty liver through nuclear factor-κB/p53/B-cell lymphoma 2-associated X protein signaling pathways in a rat model

Lu Guo, Haifeng Zhang, Xiuping Yan

Mol Med Rep. 2019 Mar; 19(3): 1638–1644. Published online 2018 Dec 20. doi: 10.3892/mmr.2018.9783

PMCID:: PMC6390035

Abstract Article PDF–1.4M

Select item 83075067.

Identification of Dihydromyricetin and Metabolites in Serum and Brain Associated with Acute Anti-Ethanol Intoxicating Effects in Mice

Eileen Carry, Dushyant Kshatriya, Joshua Silva, Daryl L. Davies, Bo Yuan, Qingli Wu, Harna Patel, Elizabeth R. Park, John Gilleran, Lihong Hao, Jacques Roberge, Nicholas T. Bello, James E. Simon

Int J Mol Sci. 2021 Jul; 22(14): 7460. Published online 2021 Jul 12. doi: 10.3390/ijms22147460

PMCID:: PMC8307506

Abstract Article PDF–1.2M

Select item 112670368.

Analysis of the role of dihydromyricetin derived from vine tea (Ampelopsis grossedentata) on multiple myeloma by activating STAT1/RIG-I axis

WEI JIANG, MEI ZHOU

Oncol Res. 2024; 32(8): 1359–1368. Published online 2024 Jul 17. doi: 10.32604/or.2024.043423

PMCID:: PMC11267036

Abstract Article PDF–6.2M

Select item 105073639.

Research progress of dihydromyricetin in the treatment of diabetes mellitus

Ziyuan Wang, Zhuoran Cao, Zhiying Yue, Zhengfeng Yang

Front Endocrinol (Lausanne) 2023; 14: 1216907. Published online 2023 Sep 4. doi: 10.3389/fendo.2023.1216907

PMCID:: PMC10507363

Abstract Article PDF–869K

Select item 981498410.

Molecular Mechanisms and Promising Role of Dihydromyricetin in Cardiovascular Diseases

Hao NIE, Tianyi JI, Yu FU, Danyang CHEN, Zhouping TANG, Cuntai ZHANG

Physiol Res. 2022 Dec; 71(6): 749–762. Published online 2022 Nov 25. doi: 10.33549/physiolres.934915

PMCID:: PMC9814984

Abstract Article PDF–567K

Select item 1136373811.

Design, synthesis, and biological activity evaluation of dihydromyricetin derivatives against SARS-CoV-2-Omicron virus

Cong Wu, Qi Jiang, Hui Zhong, Xudong Zhou, Leping Liu, Tong Pan, Chao Liu, Wei Wang, Wenbing Sheng

J Enzyme Inhib Med Chem. 2024; 39(1): 2390909. Published online 2024 Aug 29. doi: 10.1080/14756366.2024.2390909

PMCID:: PMC11363738

Abstract Article PDF–1.5M

Select item 965685912.

Dihydromyricetin Enhances Exercise-Induced GLP-1 Elevation through Stimulating cAMP and Inhibiting DPP-4

Luting Wu, Min Zhou, Yingquan Xie, Hedong Lang, Tianyou Li, Long Yi, Qianyong Zhang, Mantian Mi

Nutrients. 2022 Nov; 14(21): 4583. Published online 2022 Nov 1. doi: 10.3390/nu14214583

PMCID:: PMC9656859

Abstract Article PDF–4.2M

Select item 669566213.

Antibacterial Activity and Mode of Action of Dihydromyricetin from Ampelopsis grossedentata Leaves against Food-Borne Bacteria

Xiao-Nian Xiao, Fan Wang, Yi-Ting Yuan, Jing Liu, Yue-Zhen Liu, Xing Yi

Molecules. 2019 Aug; 24(15): 2831. Published online 2019 Aug 3. doi: 10.3390/molecules24152831

PMCID:: PMC6695662

Abstract Article PDF–2.6M

Select item 622520814.

Dihydromyricetin as a Functional Additive to Enhance Antioxidant Capacity and Inhibit the Formation of Thermally Induced Food Toxicants in a Cookie Model

Jing Teng, Xuduo Liu, Xiaoqian Hu, Yueliang Zhao, Ning-Ping Tao, Mingfu Wang

Molecules. 2018 Sep; 23(9): 2184. Published online 2018 Aug 30. doi: 10.3390/molecules23092184

PMCID:: PMC6225208

Abstract Article PDF–1.1M

Select item 658449015.

Dihydromyricetin protects HUVECs of oxidative damage induced by sodium nitroprusside through activating PI3K/Akt/FoxO3a signalling pathway

Xiaoying Zhang, Lifang Wang, Lizhi Peng, Xiaoying Tian, Xiaoyuan Qiu, Huan Cao, Qiaohong Yang, Rifang Liao, Fengxia Yan

J Cell Mol Med. 2019 Jul; 23(7): 4829–4838. Published online 2019 May 21. doi: 10.1111/jcmm.14406

PMCID:: PMC6584490

Abstract Article PDF–1.5M

Select item 765620816.

Dihydromyricetin ameliorates chronic liver injury by reducing pyroptosis

Quan-Cheng Cheng, Jing Fan, Xin-Wei Deng, Huai-Cun Liu, Hui-Ru Ding, Xuan Fang, Jian-Wei Wang, Chun-Hua Chen, Wei-Guang Zhang

World J Gastroenterol. 2020 Nov 7; 26(41): 6346–6360. Published online 2020 Nov 7. doi: 10.3748/wjg.v26.i41.6346

PMCID:: PMC7656208

Abstract Article PDF–21M

Select item 947715417.

Dihydromyricetin Attenuates Cerebral Ischemia Reperfusion Injury by Inhibiting SPHK1/mTOR Signaling and Targeting Ferroptosis

Jiangbo Xie, Tingting Zhang, Peichun Li, Dong Wang, Tao Liu, Shunliang Xu

Drug Des Devel Ther. 2022; 16: 3071–3085. Published online 2022 Sep 11. doi: 10.2147/DDDT.S378786

PMCID:: PMC9477154

Abstract Article PDF–10M

Select item 721415018.

Dihydromyricetin increases endothelial nitric oxide production and inhibits atherosclerosis through microRNA‐21 in apolipoprotein E‐deficient mice

Dafeng Yang, Zhousheng Yang, Lei Chen, Dabin Kuang, Yang Zou, Jie Li, Xu Deng, Songyuan Luo, Jianfang Luo, Jun He, Miao Yan, Guixia He, Yang Deng, Rong Li, Qiong Yuan, Yangzhao Zhou, Pei Jiang, Shenglan Tan

J Cell Mol Med. 2020 May; 24(10): 5911–5925. Published online 2020 Apr 17. doi: 10.1111/jcmm.15278

PMCID:: PMC7214150

Abstract Article PDF–2.6M

Select item 441365119.

Dihydromyricetin prevents cardiotoxicity and enhances anticancer activity induced by adriamycin

Hong Zhu, Peihua Luo, Yingying Fu, Jincheng Wang, Jiabin Dai, Jinjin Shao, Xiaochun Yang, Linlin Chang, Qinjie Weng, Bo Yang, Qiaojun He

Oncotarget. 2015 Feb; 6(5): 3254–3267. Published online 2014 Sep 5. doi: 10.18632/oncotarget.2410

PMCID:: PMC4413651

Abstract Article PDF–7.6M

Select item 628296620.

Dihydromyricetin inhibits microglial activation and neuroinflammation by suppressing NLRP3 inflammasome activation in APP/PS1 transgenic mice

Jie Feng, Jing‐Xue Wang, Ye‐Hong Du, Ying Liu, Wei Zhang, Jing‐Fei Chen, Yuan‐Jie Liu, Min Zheng, Ke‐Jian Wang, Gui‐Qiong He

CNS Neurosci Ther. 2018 Dec; 24(12): 1207–1218. Published online 2018 Jun 4. doi: 10.1111/cns.12983

PMCID:: PMC6282966

Abstract Article PDF–1.7M

<< First< Prev

Page of 154

Next >Last >>

Supplemental Content

Filter your results:

Manage Filters

PMC Images search for Dihydromyricetin

Fig. 1

Docked conformations of dihydromyricetin in SARS-CoV-2 M^pro proteases and the inhibitory activity of dihydromyricetin in vitro. A. The structure and docking score of dihydromyricetin. B. Dihydromyricetin docking to the SARS-CoV-2 M^pro protein X-ray structure (Protein Data Bank accession No.6LU7).

Effect of dihydromyricetin on SARS-CoV-2 viral replication and pulmonary inflammation and fibrosis

Phytomedicine. 2021 Oct;91:153704-153704.
Fig 6Dihydromyricetin is a competitive inhibitor for dihydropyrimidinase.

Kinetic study of dihydropyrimidinase with (open circles) and without dihydromyricetin (close circles). Inhibition of dihydropyrimidinase by dihydromyricetin (40 μM) resulted in Lineweaver–Burk plots where the lines are cross the y-axis at the similar point, indicating that dihydromyricetin is a competitive inhibitor for dihydropyrimidinase. Data points are an average of 2–3 determinations within 10% error.

Inhibition of a Putative Dihydropyrimidinase from Pseudomonas aeruginosa PAO1 by Flavonoids and Substrates of Cyclic Amidohydrolases

PLoS One. 2015;10(5):e0127634.
Figure 1

The structure of dihydromyricetin (1) and its metabolites (2–8).

The Versatile Effects of Dihydromyricetin in Health

Evid Based Complement Alternat Med. 2017;2017:1053617.
FIGURE 1

Chemical structure of dihydromyricetin.

Dihydromyricetin Alleviates Pulmonary Fibrosis by Regulating Abnormal Fibroblasts Through the STAT3/p-STAT3/GLUT1 Signaling Pathway

Front Pharmacol. 2022;13:834604.